
M. Franco G. Salvoza
Examiner (ID: 7827, Phone: (571)272-4468 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1671, 1672 |
| Total Applications | 792 |
| Issued Applications | 451 |
| Pending Applications | 119 |
| Abandoned Applications | 244 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11082267
[patent_doc_number] => 20160279232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'Gene-Deleted Variant Strain Of Porcine Pseudorabies Virus, Vaccine Composition, Method Of Making The Same And Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/054404
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12103
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054404
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054404 | Gene-Deleted Variant Strain Of Porcine Pseudorabies Virus, Vaccine Composition, Method Of Making The Same And Use Thereof | Feb 25, 2016 | Abandoned |
Array
(
[id] => 12751276
[patent_doc_number] => 20180142259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING GENETIC EYE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/551869
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551869 | Methods and compositions for treating genetic eye diseases | Feb 21, 2016 | Issued |
Array
(
[id] => 12814039
[patent_doc_number] => 20180163183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLE PURIFICATION WITH MULTIPLE-STEP ANION EXCHANGE CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 15/549279
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549279
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549279 | Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography | Feb 8, 2016 | Issued |
Array
(
[id] => 12158829
[patent_doc_number] => 20180030096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'RECOMBINANT AAV1, AAV5, AND AAV6 CAPSID MUTANTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/548728
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15938
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548728 | RECOMBINANT AAV1, AAV5, AND AAV6 CAPSID MUTANTS AND USES THEREOF | Feb 2, 2016 | Abandoned |
Array
(
[id] => 11025111
[patent_doc_number] => 20160222067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'NOVEL AAV\'S AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/007559
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36512
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/007559 | AAV's and uses thereof | Jan 26, 2016 | Issued |
Array
(
[id] => 12125116
[patent_doc_number] => 20180008703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'ALUM-CONTAINING COATING FORMULATIONS FOR MICRONEEDLE VACCINE PATCHES'
[patent_app_type] => utility
[patent_app_number] => 15/544993
[patent_app_country] => US
[patent_app_date] => 2016-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13926
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544993 | ALUM-CONTAINING COATING FORMULATIONS FOR MICRONEEDLE VACCINE PATCHES | Jan 17, 2016 | Abandoned |
Array
(
[id] => 10997441
[patent_doc_number] => 20160194387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'Methods Of Treating Inflammation Associated Airway Diseases And Viral Infections'
[patent_app_type] => utility
[patent_app_number] => 14/985591
[patent_app_country] => US
[patent_app_date] => 2015-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15171
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985591
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/985591 | Methods of treating inflammation associated airway diseases and viral infections | Dec 30, 2015 | Issued |
Array
(
[id] => 10767874
[patent_doc_number] => 20160114029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'PORCINE PSEUDORABIES VIRUS, VACCINE COMPOSITION AND PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/980673
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6871
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980673
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980673 | Porcine pseudorabies virus, vaccine composition and preparation method and use thereof | Dec 27, 2015 | Issued |
Array
(
[id] => 10782950
[patent_doc_number] => 20160129106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'Method for preparing virosomes'
[patent_app_type] => utility
[patent_app_number] => 14/998169
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4970
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14998169
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/998169 | Method for preparing virosomes | Dec 22, 2015 | Abandoned |
Array
(
[id] => 15338833
[patent_doc_number] => 10525072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => 2'-branched nucleosides and flaviviridae mutation
[patent_app_type] => utility
[patent_app_number] => 14/972009
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 39162
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14972009
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/972009 | 2'-branched nucleosides and flaviviridae mutation | Dec 15, 2015 | Issued |
Array
(
[id] => 12162785
[patent_doc_number] => 20180034051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'VACCINES BASED ON HEPATITIS B CORE ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 15/532466
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 4891
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532466 | VACCINES BASED ON HEPATITIS B CORE ANTIGENS | Dec 2, 2015 | Abandoned |
Array
(
[id] => 10805234
[patent_doc_number] => 20160151390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)'
[patent_app_type] => utility
[patent_app_number] => 14/957745
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 29321
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14957745
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/957745 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) | Dec 2, 2015 | Abandoned |
Array
(
[id] => 10750889
[patent_doc_number] => 20160097040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY'
[patent_app_type] => utility
[patent_app_number] => 14/956934
[patent_app_country] => US
[patent_app_date] => 2015-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 112
[patent_figures_cnt] => 112
[patent_no_of_words] => 31963
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14956934
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/956934 | Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby | Dec 1, 2015 | Issued |
Array
(
[id] => 13699931
[patent_doc_number] => 20170360920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => METHOD AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF A HIV INFECTION
[patent_app_type] => utility
[patent_app_number] => 15/528230
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/528230 | METHOD AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF A HIV INFECTION | Nov 19, 2015 | Abandoned |
Array
(
[id] => 10755985
[patent_doc_number] => 20160102137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'CROSSLINKED ANTI-HIV-1 COMPOSITIONS FOR POTENT AND BROAD NEUTRALIZATION'
[patent_app_type] => utility
[patent_app_number] => 14/872051
[patent_app_country] => US
[patent_app_date] => 2015-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 15409
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872051
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872051 | CROSSLINKED ANTI-HIV-1 COMPOSITIONS FOR POTENT AND BROAD NEUTRALIZATION | Sep 29, 2015 | Abandoned |
Array
(
[id] => 10483708
[patent_doc_number] => 20150368727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'NUCLEIC ACID AMPLIFICATION CONTROLS'
[patent_app_type] => utility
[patent_app_number] => 14/841053
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10456
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14841053
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/841053 | NUCLEIC ACID AMPLIFICATION CONTROLS | Aug 30, 2015 | Abandoned |
Array
(
[id] => 11837888
[patent_doc_number] => 20170219607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Method For Identifying Epitope On Protein'
[patent_app_type] => utility
[patent_app_number] => 15/326295
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 23596
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326295 | Method for identifying epitope on protein | Jul 12, 2015 | Issued |
Array
(
[id] => 10662233
[patent_doc_number] => 20160008374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV'
[patent_app_type] => utility
[patent_app_number] => 14/795676
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 114378
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795676 | Modulators of toll-like receptors for the treatment of HIV | Jul 8, 2015 | Issued |
Array
(
[id] => 11082266
[patent_doc_number] => 20160279231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'A Method of Attenuating Porcine Pseudorabies Virus, Attenuated Strains of Porcine Pseudorabies Virus, Vaccine Composition and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/030345
[patent_app_country] => US
[patent_app_date] => 2015-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22221
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/030345 | Method of attenuating porcine pseudorabies virus, attenuated strains of porcine pseudorabies virus, vaccine composition and use thereof | Jul 5, 2015 | Issued |
Array
(
[id] => 11901081
[patent_doc_number] => 09770501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof'
[patent_app_type] => utility
[patent_app_number] => 14/790462
[patent_app_country] => US
[patent_app_date] => 2015-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 8709
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790462
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/790462 | Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof | Jul 1, 2015 | Issued |